Journal Article DKFZ-2025-02460

http://join2-wiki.gsi.de/foswiki/pub/Main/Artwork/join2_logo100x88.png
Tumor Necrosis Factor α: Taking a Personalized Road in Cancer Therapy.



2022
Frontiers Media Lausanne

Frontiers in immunology 13, 903679 () [10.3389/fimmu.2022.903679]
 GO

Keyword(s): Humans (MeSH) ; Neoplasms: drug therapy (MeSH) ; Receptors, Tumor Necrosis Factor, Type I (MeSH) ; Receptors, Tumor Necrosis Factor, Type II (MeSH) ; Tumor Necrosis Factor-alpha (MeSH) ; TNFR1 ; TNFR2 ; cancer ; personalized therapy ; tumor necrosis factor α/TNFα ; Receptors, Tumor Necrosis Factor, Type I ; Receptors, Tumor Necrosis Factor, Type II ; Tumor Necrosis Factor-alpha

Classification:

Note: #DKFZ-MOST-Ca187#


Database coverage:
Medline ; Creative Commons Attribution CC BY (No Version) ; DOAJ ; Article Processing Charges ; Clarivate Analytics Master Journal List ; DOAJ Seal ; Essential Science Indicators ; Fees ; IF >= 5 ; JCR ; SCOPUS ; Science Citation Index Expanded ; Web of Science Core Collection
Click to display QR Code for this record

The record appears in these collections:
External Publications > Coordinated Projects
Institute Collections > W500

 Record created 2025-11-18, last modified 2025-11-18


Rate this document:

Rate this document:
1
2
3
 
(Not yet reviewed)